Koyfin Home > Directory > Health Care > Kiniksa Pharmaceuticals Ltd > Diluted EPS Excl. Extra Items

Kiniksa Pharmaceuticals Ltd Diluted EPS Excl. Extra Items Chart (KNSA)

Kiniksa Pharmaceuticals Ltd annual/quarterly Diluted EPS Excl. Extra Items from 2017 to 2020. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Kiniksa Pharmaceuticals Ltd Diluted EPS Excl. Extra Items for the quarter ending September 09, 2020 was $-1m a 12.83% decrease of 0m year over year
  • Kiniksa Pharmaceuticals Ltd Diluted EPS Excl. Extra Items for the last 12 months ending September 09, 2020 was $-2m a -25.66% increase of 1m year over year
  • Kiniksa Pharmaceuticals Ltd Annual Diluted EPS Excl. Extra Items for 2019 was $-3m a -16.66% increase of 0m from 2018
  • Kiniksa Pharmaceuticals Ltd Annual Diluted EPS Excl. Extra Items for 2018 was $-3m a -926.06% increase of 32m from 2017
  • Kiniksa Pharmaceuticals Ltd Annual Diluted EPS Excl. Extra Items for 2017 was $-36m a -155.55% increase of 56m from 2016
Other Per Share Metrics:
  • Kiniksa Pharmaceuticals Ltd Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a -633.73% increase of 6m year over year
View Chart On Koyfin

Quarterly KNSA Diluted EPS Excl. Extra Items Data

09/2020$-1m
06/2020$-1m
03/2020$0m
12/2019$-1m
09/2019$0m
06/2019$-1m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$-1m

Annual KNSA Diluted EPS Excl. Extra Items Data

2019$-3m
2018$-3m
2017$-36m
2016$-92m